ATE380048T1 - Behandlung der männlichen sexuellen dysfunktion - Google Patents

Behandlung der männlichen sexuellen dysfunktion

Info

Publication number
ATE380048T1
ATE380048T1 AT04743961T AT04743961T ATE380048T1 AT E380048 T1 ATE380048 T1 AT E380048T1 AT 04743961 T AT04743961 T AT 04743961T AT 04743961 T AT04743961 T AT 04743961T AT E380048 T1 ATE380048 T1 AT E380048T1
Authority
AT
Austria
Prior art keywords
sexual dysfunction
male sexual
ejaculation
treating male
treatment
Prior art date
Application number
AT04743961T
Other languages
English (en)
Inventor
Christopher P Wayman
Rachel J Russell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE380048T1 publication Critical patent/ATE380048T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT04743961T 2003-07-23 2004-07-12 Behandlung der männlichen sexuellen dysfunktion ATE380048T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0317227.7A GB0317227D0 (en) 2003-07-23 2003-07-23 Treatment of male sexual dysfunction

Publications (1)

Publication Number Publication Date
ATE380048T1 true ATE380048T1 (de) 2007-12-15

Family

ID=27772516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743961T ATE380048T1 (de) 2003-07-23 2004-07-12 Behandlung der männlichen sexuellen dysfunktion

Country Status (12)

Country Link
EP (1) EP1656183B1 (de)
JP (1) JP2006528171A (de)
AT (1) ATE380048T1 (de)
BR (1) BRPI0412255A (de)
CA (1) CA2533177A1 (de)
CL (1) CL2004001702A1 (de)
GB (1) GB0317227D0 (de)
MX (1) MXPA05014200A (de)
TW (1) TW200510424A (de)
UA (1) UA79674C2 (de)
WO (1) WO2005006899A1 (de)
ZA (1) ZA200505957B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637553B2 (en) 2003-07-23 2014-01-28 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
GB0504556D0 (en) * 2005-03-04 2005-04-13 Pfizer Ltd Novel pharmaceuticals
WO2006100557A1 (en) * 2005-03-21 2006-09-28 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
US20220152032A1 (en) * 2020-11-13 2022-05-19 Pharma America Holding Inc. Sexual therapy formulation and method of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058880A1 (fr) * 2000-02-08 2001-08-16 Yamanouchi Pharmaceutical Co., Ltd. Derives de triazole
GB0224919D0 (en) * 2002-10-25 2002-12-04 Pfizer Ltd Triazole compounds useful in therapy

Also Published As

Publication number Publication date
ZA200505957B (en) 2006-11-29
EP1656183B1 (de) 2007-12-05
MXPA05014200A (es) 2006-07-03
TW200510424A (en) 2005-03-16
WO2005006899A1 (en) 2005-01-27
CA2533177A1 (en) 2005-01-27
EP1656183A1 (de) 2006-05-17
UA79674C2 (en) 2007-07-10
JP2006528171A (ja) 2006-12-14
BRPI0412255A (pt) 2006-09-19
CL2004001702A1 (es) 2005-05-13
GB0317227D0 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
MXPA03007513A (es) Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
TW200745031A (en) Acyl indoles, compositions containing such compounds and methods of use
TW200800959A (en) Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
EA200501504A1 (ru) Лиганды каннабиноидных рецепторов и их применение
MX2007002393A (es) Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
SE0203713D0 (sv) Novel compounds
GB0504828D0 (en) Therapeutic agents
MY161834A (en) Substituted diazepan compounds as orexin receptor antagonists
TW200801013A (en) Substituted benzofused derivatives and their use as vanilloid receptor ligands
EA200701979A1 (ru) Способ получения опиоидных модуляторов
EP1804919A4 (de) Cgrp-rezeptorantagonisten
HK1088004A1 (en) 3-heterocyclyl-azetidine compounds useful as nk1/nk2 receptors antagonists
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
HK1091200A1 (en) Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
EP1802372A4 (de) Cgrp-rezeptorantagonisten
NO20073369L (no) Modulatorer av muskarinreseptorer
TW200420543A (en) Treatment of female sexual dysfunction
EA200801734A1 (ru) Производные n-тиазол-2-илбензамида
ATE380048T1 (de) Behandlung der männlichen sexuellen dysfunktion
EA200801591A1 (ru) Антагонисты мускаринового рецептора
MXPA05012572A (es) Derivado de 5-h-benzo[d]naft[2,1-b]azepina como antagonistas selectivos del receptor d1/d5 para el tratamiento de la obesidad y trastornos del sistema nervioso central.
EA200600416A1 (ru) Производные циклопропила в качестве антагонистов рецептора nk3
EA200702332A1 (ru) Пролекарства n-тиазол-2-илбензамидных производных
WO2004067093A3 (en) Nk1 receptor antagonists for the treatment of functional dyspepsia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties